148 related articles for article (PubMed ID: 9351557)
1. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
Smart CR
Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
[TBL] [Abstract][Full Text] [Related]
2. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
Brawley OW
Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560
[TBL] [Abstract][Full Text] [Related]
3. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
4. Changes in prostate cancer incidence and treatment in USA.
Lu-Yao GL; Greenberg ER
Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093
[TBL] [Abstract][Full Text] [Related]
5. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
6. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
[TBL] [Abstract][Full Text] [Related]
9. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
10. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
Schwartz KL; Severson RK; Gurney JG; Montie JE
Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
12. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.
Cetin K; Beebe-Dimmer JL; Fryzek JP; Markus R; Carducci MA
Urology; 2010 Jun; 75(6):1396-404. PubMed ID: 19969335
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
15. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
Houston KA; King J; Li J; Jemal A
J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma trends in three counties in Sweden 1987-1996: results from a population-based national cancer register. South-East Region Prostate Cancer Group.
Sandblom G; Dufmats M; Nordenskjöld K; Varenhorst E
Cancer; 2000 Mar; 88(6):1445-53. PubMed ID: 10717629
[TBL] [Abstract][Full Text] [Related]
17. Rise and fall of radical prostatectomy rates from 1989 to 1996.
Sheikh K; Bullock C
Urology; 2002 Mar; 59(3):378-82. PubMed ID: 11880074
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening (United States).
Waterbor JW; Bueschen AJ
Cancer Causes Control; 1995 May; 6(3):267-74. PubMed ID: 7542033
[TBL] [Abstract][Full Text] [Related]
19. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening.
Merrill RM; Stephenson RA
J Urol; 2000 Feb; 163(2):503-10. PubMed ID: 10647666
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]